x

Bluejay Diagnostics, Inc. (Nasdaq:BJDX)

Health Care/Life Sciences • Medical Equipment/Supplies
CIK 1704287
Company

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.

Address
360 Massachusetts Avenue
Suite 203
Acton, Massachusetts 01720
Employees
16
Stock Info
Close
$0.8614
Day Range
0.8100 - 0.8806
52 Week Range
0.7300 - 14.0040
Average volume
58.06K
Short Interest
13.75K (02/15/24)
% of Float Shorted
0.09%
Market Cap
$986.11K
Revenue
$249.04K
Net Income
-$9.3M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$7.7090
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Indranil Dey PhD, MBA
Director
Svetlana Dey
Chairman
Douglas C Wurth
Independent Director
Donald R Chase
Independent Director
Frederick Schwartz Zeidman MBA
Independent Director
Gary G Gemignani
SEC filings
DateFormEvent
30 Aug, 2024 PRE 14A
28 Aug, 2024 8-K
21 Aug, 2024 8-K
14 Aug, 2024 10-Q
16 Jul, 2024 DEF 14A
5 Jul, 2024 PRE 14A
3 Jul, 2024 SC 13G
28 Jun, 2024 8-K
28 Jun, 2024 424B1
26 Jun, 2024 EFFECT
25 Jun, 2024 CORRESP
25 Jun, 2024 CORRESP
24 Jun, 2024 S-1/A
24 Jun, 2024 UPLOAD
20 Jun, 2024 8-K
17 Jun, 2024 S-1
31 May, 2024 8-K
16 May, 2024 8-K
15 May, 2024 10-Q
15 Apr, 2024 DEF 14A
5 Apr, 2024 PRE 14A
2 Apr, 2024 8-K CEO Change
28 Mar, 2024 10-K
4 Mar, 2024 8-K
14 Feb, 2024 SC 13G
3 Jan, 2024 SC 13G
2 Jan, 2024 8-K
29 Dec, 2023 424B4
27 Dec, 2023 EFFECT
27 Dec, 2023 8-K
27 Dec, 2023 S-1/A
22 Dec, 2023 CORRESP
22 Dec, 2023 CORRESP
21 Dec, 2023 S-1/A
14 Dec, 2023 4
14 Dec, 2023 4
30 Nov, 2023 UPLOAD
21 Nov, 2023 S-1
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
26 Oct, 2023 8-K
16 Oct, 2023 8-K
11 Oct, 2023 3
2 Oct, 2023 8-K
28 Aug, 2023 8-K
28 Aug, 2023 424B5
16 Aug, 2023 8-K
14 Aug, 2023 10-Q
10 Aug, 2023 8-K
21 Jul, 2023 8-K
20 Jun, 2023 EFFECT
15 Jun, 2023 CORRESP
15 Jun, 2023 UPLOAD
5 Jun, 2023 S-3
19 May, 2023 8-K
18 May, 2023 DEF 14A
11 May, 2023 10-Q
10 May, 2023 8-K
8 May, 2023 PRE 14A
1 May, 2023 10-K/A
27 Apr, 2023 8-K
31 Mar, 2023 4/A
31 Mar, 2023 4/A
28 Mar, 2023 4
24 Mar, 2023 4
20 Mar, 2023 10-K
20 Mar, 2023 8-K
16 Mar, 2023 3
16 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
13 Feb, 2023 4
27 Jan, 2023 8-K
9 Nov, 2022 10-Q
8 Nov, 2022 8-K
28 Oct, 2022 8-K
7 Sep, 2022 4
10 Aug, 2022 10-Q
26 Jul, 2022 8-K
15 Jun, 2022 8-K
13 May, 2022 DEF 14A
9 May, 2022 10-Q
27 Apr, 2022 4
20 Apr, 2022 8-K
19 Apr, 2022 S-8
1 Apr, 2022 8-K
28 Mar, 2022 8-K
28 Mar, 2022 3
28 Mar, 2022 4
23 Mar, 2022 4
23 Mar, 2022 4
23 Mar, 2022 4
23 Mar, 2022 4
23 Mar, 2022 4
21 Mar, 2022 4
21 Mar, 2022 4
18 Mar, 2022 4
17 Mar, 2022 4
16 Mar, 2022 4
10 Mar, 2022 8-K
10 Mar, 2022 10-K
28 Feb, 2022 4
28 Feb, 2022 4
31 Jan, 2022 8-K
13 Jan, 2022 4
13 Jan, 2022 4
13 Jan, 2022 4
13 Jan, 2022 4
4 Jan, 2022 SC 13G/A
22 Dec, 2021 SC 13D
22 Dec, 2021 SC 13D
17 Dec, 2021 4
16 Dec, 2021 10-Q
16 Dec, 2021 8-K
24 Nov, 2021 3
17 Nov, 2021 SC 13G
16 Nov, 2021 8-K
12 Nov, 2021 424B4 IPO completed
9 Nov, 2021 EFFECT
9 Nov, 2021 S-1MEF
9 Nov, 2021 3
9 Nov, 2021 3
9 Nov, 2021 3
9 Nov, 2021 3
9 Nov, 2021 3
9 Nov, 2021 3
5 Nov, 2021 CORRESP
5 Nov, 2021 CORRESP
5 Nov, 2021 8-A12B
5 Nov, 2021 CERT
3 Nov, 2021 S-1/A
27 Oct, 2021 FWP
25 Oct, 2021 CORRESP
25 Oct, 2021 S-1/A
15 Oct, 2021 UPLOAD
4 Oct, 2021 S-1
4 Oct, 2021 CORRESP
24 Sep, 2021 UPLOAD
8 Sep, 2021 DRSLTR
8 Sep, 2021 DRS/A
20 Aug, 2021 UPLOAD
22 Jul, 2021 DRS
29 Jun, 2021 D
Last update:2024-03-06 13:13:19.628744
Bluejay Diagnostics, Inc. by TradingView

Sign Up to Subscribe